Keyword Analysis & Research: adocia
Keyword Research: People who searched adocia also searched
Search Results related to adocia on Search Engine
-
Adocia
https://www.bing.com/alink/link?url=https%3a%2f%2fwww.adocia.com%2f&source=serp-local&h=qIReQQJTPRCjylQ1wtXeRWebkc0IQg%2bVn4%2b%2bRNWRx3s%3d&p=lw_gbt&ig=DF1965A4FCD646A68542E305F15AE86A&ypid=YN2097x256225079
DA: 6 PA: 74 MOZ Rank: 51
-
Adocia • Innovative medicine for everone everywhere
https://www.adocia.com/
Web ResultAdocia develops innovative treatments for diabetes and obesity based on its proprietary technologies. Learn more about its products, pipeline, investors, media and contact information.
DA: 49 PA: 33 MOZ Rank: 77
-
ADOCIA | LinkedIn
https://www.linkedin.com/company/adocia
Web Result"Innovative medicine for everyone, everywhere" Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on...
DA: 39 PA: 26 MOZ Rank: 61
-
Medias and publications - Adocia
https://www.adocia.com/medias-publications/
Web Result09/14/2023 Number of shares and voting rights of ADOCIA as of August 31st, 2023. 08/31/2023 ADOCIA Announces that it has Received €500.000 in Proceeds from a Partial Exercise of Warrants Held by IPF Partners. 07/25/2023 ADOCIA announces Q2 2023 financial results and a €10 million financing operation.
DA: 71 PA: 38 MOZ Rank: 64
-
ADOCIA Reports Fourth Quarter 2023 Financial Results and
https://www.nasdaq.com/press-release/adocia-reports-fourth-quarter-2023-financial-results-and-provides-a-business-update
Web ResultDec 31, 2023 · Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical Company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes...
DA: 6 PA: 10 MOZ Rank: 33
-
ADOCIA Announces First Cell Therapy Preclinical Proof of …
https://www.businesswire.com/news/home/20220906005969/en/ADOCIA-Announces-First-Cell-Therapy-Preclinical-Proof-of-Concept-of-AdoShell%C2%AE-Islets-for-the-Treatment-of-Type-1-Diabetes
Web ResultSeptember 07, 2022 01:30 AM Eastern Daylight Time. LYON, France-- ( BUSINESS WIRE )--Regulatory News: “Adocia’s results are remarkable, having successfully performed the first islet...
DA: 23 PA: 85 MOZ Rank: 79
-
ADOCIA Grants Sanofi an Exclusive Right to Negotiate a …
https://finance.yahoo.com/news/adocia-grants-sanofi-exclusive-negotiate-163000663.html
Web ResultJul 5, 2023 · Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical Company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes...
DA: 9 PA: 74 MOZ Rank: 60